DrugId:  1
1. Name:  Rhodotorula rubra
2. Groups:  Approved
3. Description:  Rhodotorula rubra is a fungus which can provoke allergic reactions. Rhodotorula rubra is used in allergenic testing.
4. Indication:  Not Available
DrugId:  2
1. Name:  Influenza A virus A/bolivia/559/2013 (H1N1) live (attenuated) antigen
2. Groups:  Approved, Investigational
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  3
1. Name:  Influenza a virus a/california/7/2009(h1n1)-like antigen (formaldehyde inactivated)
2. Groups:  Approved
3. Description:  Influenza a virus a/california/7/2009(h1n1)-like antigen (formaldehyde inactivated) is an active immunization against disease caused by influenza virus subtypes A and type B for intramuscular injection. The vaccine is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs where the virus is purified and inactivated by formaldehyde.
4. Indication:  Not Available
DrugId:  4
1. Name:  Candida tropicalis
2. Groups:  Approved
3. Description:  Candida tropicalis is a fungus which can provoke allergic reactions. Candida tropicalis is used in allergenic testing.
4. Indication:  Not Available
DrugId:  5
1. Name:  Saccharomyces cerevisiae
2. Groups:  Approved
3. Description:  Saccharomyces cerevisiae is a fungus which can provoke allergic reactions. Saccharomyces cerevisiae is used in allergenic testing.
4. Indication:  Not Available
DrugId:  6
1. Name:  QR-333
2. Groups:  Investigational
3. Description:  QR-333 has been investigated as a treatment for diabetic peripheral neuropathy. QR-333 is a concentrated and standardized nutrient based active compounds dosed in a topical cream designed to reduce oxidative stress and treat symptoms of Diabetic Peripheral Neuropathy, a nerve disorder that can lead to numbness, skin ulcers, constant pain or extreme sensitivity to a stimulus.
4. Indication:  Investigated for use/treatment in neuropathy (diabetic).
DrugId:  7
1. Name:  Chaetomium globosum
2. Groups:  Approved
3. Description:  Chaetomium globosum is a fungus which can provoke allergic reactions. Chaetomium globosum extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  8
1. Name:  Archexin
2. Groups:  Investigational
3. Description:  Not Available
4. Indication:  Investigated for use/treatment in solid tumors.
DrugId:  9
1. Name:  Neurospora intermedia
2. Groups:  Approved
3. Description:  Neurospora intermedia is a fungus which can provoke allergic reactions. Neurospora intermedia extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  10
1. Name:  Influenza A virus A/brisbane/10/2010 (H1N1) antigen (mdck cell derived, propiolactone inactivated)
2. Groups:  Approved, Investigational
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  11
1. Name:  Lanolin
2. Groups:  Approved
3. Description:  Lanolin primarily consists of long chain waxy esters, or sterol esters, that lack glycerides. It is also called wool wax or wool grease, because it is a wax secreted by the sebaceous glands of wool-bearing animals, such as domestic sheep breeds raised for their wool. Lanolin is used in the protection, treatment and beautification of human skin. Its waterproofing properties can help skin treatment properties against infections or skin irritations as it helps seal out wetness. It is used as an active ingredient in OTC topical products such as ointments, lubricants, lotions and facial cosmetics. It is also frequently used in protective baby skin treatment and for sore nipples in breastfeeding mothers.
4. Indication:  Not Available
DrugId:  12
1. Name:  Ceramide 3
2. Groups:  Approved
3. Description:  Ceramide 3 is a lipid molecule included in a group of lipid molecules called ceramides. Ceramides are major lipid components in the stratum corneum of the human skin. Ceramide 3 consists of a phytosphingosine backbone N-acylated with a saturated fatty acid (stearic acid) [2]. It is widely used as a moisturizer in various cosmetic and personal products. Together with ceramide 1, they synergistically improve the skin barrier function in humans [1, 2].
4. Indication:  Not Available
DrugId:  13
1. Name:  Geotrichum candidum
2. Groups:  Approved
3. Description:  Geotrichum candidum is a fungus which can provoke allergic reactions. Geotrichum candidum extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  14
1. Name:  Huperzine-A
2. Groups:  Approved, Investigational
3. Description:  Huperzine-A is a naturally occurring sesquiterpene alkaloid found in the extracts of the firmoss Huperzia serrata. The botanical has traditionally been used in China for the treatment of swelling, fever and blood disorders. Recently in clinical trials in China, it has demonstrated neuroprotective effects. It is currently being investigated as a possible treatment for diseases characterized by neurodegeneration, particularly Alzheimerâ€™s disease. Huperzine A is a cholinesterase inhibitor.
4. Indication:  Investigated for use/treatment in alzheimer's disease.
DrugId:  15
1. Name:  Meningococcal group A polysaccharide
2. Groups:  Approved, Experimental, Investigational
3. Description:  Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.
4. Indication:  Not Available
DrugId:  16
1. Name:  Equine Botulinum Neurotoxin A Immune FAB2
2. Groups:  Approved, Experimental, Investigational
3. Description:  Equine Botulinum Neurotoxin A Immune FAB2 is composed of a mixture of immune globulin fragments purified from plasma of horses that were previously immunized with botulinum toxin serotype A. It is intravenously administered for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A in adults and pediatric patients.
4. Indication:  Not Available
DrugId:  17
1. Name:  PM02734
2. Groups:  Investigational
3. Description:  PM02734 is a marine derived compound. PM02734 as a new antiproliferative drug demonstrating activity against a broad spectrum of tumor types: breast, colon, pancreas, lung and prostate, among others.
4. Indication:  Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors.
DrugId:  18
1. Name:  OPC-14523
2. Groups:  Investigational
3. Description:  OPC-14523 is an antidepressant drug developed by Otsuka America Pharmaceutical.
4. Indication:  Investigated for use/treatment in bulimia, depression, and obsessive-compulsive disorders.
DrugId:  19
1. Name:  EW-A-401
2. Groups:  Investigational
3. Description:  EW-A-401 is a circle of genetic material (plasmid DNA) that instructs the body to produce a genetically-engineered transcription factor, a protein that regulates expression of genes. This specific transcription factor has been shown in animal studies to increase expression of the VEGF-A gene, and to promote the growth of new blood vessels.
4. Indication:  Investigated for use/treatment in peripheral vascular disease.
DrugId:  20
1. Name:  3-amino-5-phenylpentane
2. Groups:  Experimental
3. Description:  3-amino-5-phenylpentane is a solid. This compound belongs to the phenylpropylamines. These are compounds containing a phenylpropylamine moiety, which consists of a phenyl group substituted at the third carbon by a propan-1-amine. 3-amino-5-phenylpentane targets the proteins cathepsin K and cathepsin L2.
4. Indication:  Not Available
DrugId:  21
1. Name:  ND7001
2. Groups:  Investigational
3. Description:  ND7001, a selective PDE2 inhibitor is in clinical trials for the treatment of depression. ND7001 is a solid. Known drug targets of ND7001 including phosphodiesterase 2A, cGMP-stimulated and cGMP-dependent 3',5'-cyclic phosphodiesterase. It is a new type of antidepressant drug with anxiolytic activity. It is the first representative of a new generation of psycho-active compounds potentially devoid of several problems seen with existing treatments.
4. Indication:  Investigated for use/treatment in anxiety disorders and depression.
DrugId:  22
1. Name:  Manganese gluconate
2. Groups:  Approved
3. Description:  Manganese gluconate is a manganese salt of gluconic acid with the chemical formula C12H22MnO14 x 2H2O. It is typically obtained by reacting manganese carbonate with gluconic acid in aqueous medium and then crystallizing the product to form a slightly pink powder. Manganese gluconate is a direct ingredient in food substances as a nutrient supplement.
4. Indication:  Not Available
DrugId:  23
1. Name:  CHF-1512
2. Groups:  Investigational
3. Description:  CHF1512 is a methyl-ester of levodopa (LDME), melevodopa, combined with the decarboxylase inhibitor carbidopa.
4. Indication:  Investigated for use/treatment in parkinson's disease.
DrugId:  24
1. Name:  Botrytis cinerea
2. Groups:  Approved
3. Description:  Botrytis cinerea is a fungus which can provoke allergic reactions. Botrytis cinerea extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  25
1. Name:  Epicoccum nigrum
2. Groups:  Approved
3. Description:  Epicoccum nigrum is a fungus which can provoke allergic reactions. Epicoccum nigrum extract is used in allergenic testing.
4. Indication:  Not Available
